|
|
|
|
| LEADER |
02812nmm a2200313 u 4500 |
| 001 |
EB001886022 |
| 003 |
EBX01000000000000001049389 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
191202 ||| eng |
| 020 |
|
|
|a 9783030241315
|
| 100 |
1 |
|
|a Yazici, Yusuf
|e [editor]
|
| 245 |
0 |
0 |
|a Behçet Syndrome
|h Elektronische Ressource
|c edited by Yusuf Yazici, Gulen Hatemi, Emire Seyahi, Hasan Yazici
|
| 250 |
|
|
|a 2nd ed. 2020
|
| 260 |
|
|
|a Cham
|b Springer International Publishing
|c 2020, 2020
|
| 300 |
|
|
|a XVI, 328 p. 98 illus., 75 illus. in color
|b online resource
|
| 505 |
0 |
|
|a Chapter 1. Introduction -- Chapter 2. Disease Definition and Epidemiology -- Chapter 3. Skin Mucosa Involvement and the Pathergy Reaction -- Chapter 4. Eye Disease -- Chapter 5. Nervous System Disease -- Chapter 6. Lung Disease -- Chapter 7. Peripheral Vascular and Cardiac Disease -- Chapter 8. Locomotor System Disease -- Chapter 9. Gastrointestinal Involvement -- Chapter 10. Other Clinical Aspects -- Chapter 11. Pediatric Behçet's Syndrome -- Chapter 12. Histopathology -- Chapter 13. Behçet’s Syndrome and Microbes -- Chapter 14. Thrombophilia in Behçet’s Syndrome -- Chapter 15. Genetics and Epigenetics -- Chapter 16. Disease Mechanisms -- Chapter 17. Prognosis -- Chapter 18. Disease Assessment -- Chapter 19. Management -- Chapter 20. The Patient’s View -- Chapter 21. Future Research Considerations
|
| 653 |
|
|
|a Ophthalmology
|
| 653 |
|
|
|a Dermatology
|
| 653 |
|
|
|a Rheumatology
|
| 700 |
1 |
|
|a Hatemi, Gulen
|e [editor]
|
| 700 |
1 |
|
|a Seyahi, Emire
|e [editor]
|
| 700 |
1 |
|
|a Yazici, Hasan
|e [editor]
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b Springer
|a Springer eBooks 2005-
|
| 028 |
5 |
0 |
|a 10.1007/978-3-030-24131-5
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-3-030-24131-5?nosfx=y
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 616.723
|
| 520 |
|
|
|a The expanded second edition of this important work provides an up-to-date and comprehensive overview of Behçet syndrome. New and updated chapters focus on recent advances in the areas of pathogenesis, the microbiome, genetics and epigenetics, clustering of symptoms, disease assessment and new treatment options. The book examines how these developments have changed the way physicians approach diagnosis, treatment, and management of Behçet patients. It also analyzes the wide variety of clinical manifestations of the disease including mucocutaneous lesions, intraocular inflammation, central nervous system involvement, deep vein thrombosis and other forms of major vascular disease. Building on the success of its predecessor, the Second Edition of Behçet Syndrome is an invaluable resource for physicians, residents, fellows, and graduate students in rheumatology, dermatology, ophthalmology, neurology, gastroenterology, and internal medicine
|